These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 35952322)

  • 21. Exome Sequencing of African-American Prostate Cancer Reveals Loss-of-Function
    Huang FW; Mosquera JM; Garofalo A; Oh C; Baco M; Amin-Mansour A; Rabasha B; Bahl S; Mullane SA; Robinson BD; Aldubayan S; Khani F; Karir B; Kim E; Chimene-Weiss J; Hofree M; Romanel A; Osborne JR; Kim JW; Azabdaftari G; Woloszynska-Read A; Sfanos K; De Marzo AM; Demichelis F; Gabriel S; Van Allen EM; Mesirov J; Tamayo P; Rubin MA; Powell IJ; Garraway LA
    Cancer Discov; 2017 Sep; 7(9):973-983. PubMed ID: 28515055
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Functional genomics of Ewing sarcoma].
    Grünewald TGP
    Pathologe; 2017 Nov; 38(Suppl 2):198-201. PubMed ID: 28849372
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CRISPR-Cas9 knockout screening identifies KIAA1429 as an essential gene in Ewing sarcoma.
    Tan K; Lu W; Chen F; Shi H; Ma Y; Chen Z; Wu W; Lv Z; Mo J
    J Exp Clin Cancer Res; 2023 Sep; 42(1):250. PubMed ID: 37759224
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Repression of the gene encoding the TGF-beta type II receptor is a major target of the EWS-FLI1 oncoprotein.
    Hahm KB; Cho K; Lee C; Im YH; Chang J; Choi SG; Sorensen PH; Thiele CJ; Kim SJ
    Nat Genet; 1999 Oct; 23(2):222-7. PubMed ID: 10508522
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chimeric EWSR1-FLI1 regulates the Ewing sarcoma susceptibility gene EGR2 via a GGAA microsatellite.
    Grünewald TG; Bernard V; Gilardi-Hebenstreit P; Raynal V; Surdez D; Aynaud MM; Mirabeau O; Cidre-Aranaz F; Tirode F; Zaidi S; Perot G; Jonker AH; Lucchesi C; Le Deley MC; Oberlin O; Marec-Bérard P; Véron AS; Reynaud S; Lapouble E; Boeva V; Rio Frio T; Alonso J; Bhatia S; Pierron G; Cancel-Tassin G; Cussenot O; Cox DG; Morton LM; Machiela MJ; Chanock SJ; Charnay P; Delattre O
    Nat Genet; 2015 Sep; 47(9):1073-8. PubMed ID: 26214589
    [TBL] [Abstract][Full Text] [Related]  

  • 26. BET bromodomain inhibitors suppress EWS-FLI1-dependent transcription and the IGF1 autocrine mechanism in Ewing sarcoma.
    Loganathan SN; Tang N; Fleming JT; Ma Y; Guo Y; Borinstein SC; Chiang C; Wang J
    Oncotarget; 2016 Jul; 7(28):43504-43517. PubMed ID: 27259270
    [TBL] [Abstract][Full Text] [Related]  

  • 27. DNA methylation profiling distinguishes Ewing-like sarcoma with EWSR1-NFATc2 fusion from Ewing sarcoma.
    Koelsche C; Kriegsmann M; Kommoss FKF; Stichel D; Kriegsmann K; Vokuhl C; Grünewald TGP; Romero-Pérez L; Kirchner T; de Alava E; Diaz-Martin J; Hartmann W; Baumhoer D; Antonescu CR; Szuhai K; Flucke U; Dirksen U; Pfister SM; Jones DTW; Mechtersheimer G; von Deimling A
    J Cancer Res Clin Oncol; 2019 May; 145(5):1273-1281. PubMed ID: 30895378
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Targeting the EWS-ETS transcriptional program by BET bromodomain inhibition in Ewing sarcoma.
    Hensel T; Giorgi C; Schmidt O; Calzada-Wack J; Neff F; Buch T; Niggli FK; Schäfer BW; Burdach S; Richter GH
    Oncotarget; 2016 Jan; 7(2):1451-63. PubMed ID: 26623725
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Overexpression of HOX genes is prevalent in Ewing sarcoma and is associated with altered epigenetic regulation of developmental transcription programs.
    Svoboda LK; Harris A; Bailey NJ; Schwentner R; Tomazou E; von Levetzow C; Magnuson B; Ljungman M; Kovar H; Lawlor ER
    Epigenetics; 2014 Dec; 9(12):1613-25. PubMed ID: 25625846
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Review with novel markers facilitates precise categorization of 41 cases of diagnostically challenging, "undifferentiated small round cell tumors". A clinicopathologic, immunophenotypic and molecular analysis.
    Machado I; Yoshida A; Morales MGN; Abrahão-Machado LF; Navarro S; Cruz J; Lavernia J; Parafioriti A; Picci P; Llombart-Bosch A
    Ann Diagn Pathol; 2018 Jun; 34():1-12. PubMed ID: 29661713
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mutational landscape of primary and recurrent Ewing sarcoma.
    Jagodzińska-Mucha P; Sobczuk P; Mikuła M; Raciborska A; Dawidowska A; Kulecka M; Bilska K; Szumera-Ciećkiewicz A; Kluska A; Piątkowska M; Bałabas A; Rutkowski P; Ługowska I
    Contemp Oncol (Pozn); 2021; 25(4):241-248. PubMed ID: 35079231
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Primary superficial Ewing sarcoma: A unique entity? A case report including novel findings of ELF3 and TNFRSF14 copy number loss.
    Murphy LD; Orman GM; Bridge JA; Bajaj G; Gardner JM; Douglass DP
    J Cutan Pathol; 2020 Oct; 47(10):970-975. PubMed ID: 32483824
    [TBL] [Abstract][Full Text] [Related]  

  • 33. ERF mutations reveal a balance of ETS factors controlling prostate oncogenesis.
    Bose R; Karthaus WR; Armenia J; Abida W; Iaquinta PJ; Zhang Z; Wongvipat J; Wasmuth EV; Shah N; Sullivan PS; Doran MG; Wang P; Patruno A; Zhao Y; ; Zheng D; Schultz N; Sawyers CL
    Nature; 2017 Jun; 546(7660):671-675. PubMed ID: 28614298
    [TBL] [Abstract][Full Text] [Related]  

  • 34. ERF: an ETS domain protein with strong transcriptional repressor activity, can suppress ets-associated tumorigenesis and is regulated by phosphorylation during cell cycle and mitogenic stimulation.
    Sgouras DN; Athanasiou MA; Beal GJ; Fisher RJ; Blair DG; Mavrothalassitis GJ
    EMBO J; 1995 Oct; 14(19):4781-93. PubMed ID: 7588608
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ewing sarcoma inhibition by disruption of EWSR1-FLI1 transcriptional activity and reactivation of p53.
    van der Ent W; Jochemsen AG; Teunisse AF; Krens SF; Szuhai K; Spaink HP; Hogendoorn PC; Snaar-Jagalska BE
    J Pathol; 2014 Aug; 233(4):415-24. PubMed ID: 24974828
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Epigenetic and Transcriptional Signaling in Ewing Sarcoma-Disease Etiology and Therapeutic Opportunities.
    Li M; Chen CW
    Biomedicines; 2022 Jun; 10(6):. PubMed ID: 35740349
    [TBL] [Abstract][Full Text] [Related]  

  • 37. EWSR1-FLI1 Activation of the Cancer/Testis Antigen FATE1 Promotes Ewing Sarcoma Survival.
    Gallegos ZR; Taus P; Gibbs ZA; McGlynn K; Gomez NC; Davis I; Whitehurst AW
    Mol Cell Biol; 2019 Jul; 39(14):. PubMed ID: 31036566
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Primary intracranial Ewing sarcoma/ peripheral primitive neuroectodermal tumor, an entity of unacquaintance: a series of 8 cases.
    Deshpande G; Epari S; Gupta C; Shetty O; Gurav M; Chinnaswamy G; Moiyadi A; Gupta T
    Childs Nerv Syst; 2021 Mar; 37(3):839-849. PubMed ID: 32761378
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The prognostic signature of the somatic mutations in Ewing sarcoma: from a network view.
    Zhang Y; Song J; Shi Q; Song X; Shen L; Zhou J; Shao J
    Jpn J Clin Oncol; 2019 Jul; 49(7):604-613. PubMed ID: 30927420
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Risk stratification by somatic mutation burden in Ewing sarcoma.
    Liu KX; Lamba N; Hwang WL; Niemierko A; DuBois SG; Haas-Kogan DA
    Cancer; 2019 Apr; 125(8):1357-1364. PubMed ID: 30602061
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.